Nardev Ramanathan leads Lux Research’s coverage of the Digital Health and Wellness and is a key contributor to the Digital Transformation and Consumer Choices in Food, Health and Wellness programs. Nardev has deep expertise in genomics, digital therapeutic products (digiceuticals), and personalized health solutions. Prior to joining Lux, Nardev was Assistant Head of the Industrial Development Group at the Agency for Science, Technology and Research (A*STAR), Singapore where he was the Precision Medicine and Digital Health lead. In that role, he helped develop an industry consortium to support the local biotech ecosystem for Precision Medicine related initiatives in Singapore. Nardev received his PhD in Clinical Biochemistry from the University of Cambridge under the A*STAR Overseas PhD scholarship. For his doctoral thesis, he identified a novel genetic mutation that leads to a rare inherited disease called lipodystrophy in a patient in the Middle East and further went on to elucidate the molecular mechanism underlying the disease.